🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the onset and duration of action o...
Status
Completed
Location
Ora, Inc.
Start Date
2013-06
Trial ID
NCT01881113
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of different concentr...
Status
Completed
Location
Ora, Inc.
Start Date
2011-04
Trial ID
NCT01332188
Treatments Being Tested
The purpose of this study is to evaluate the onset and duration of action o...
Status
Completed
Location
Andover Eye Associates
Start Date
2012-09
Trial ID
NCT01685242
Treatments Being Tested
The purpose of the study is to assess the efficacy comparability of cetiriz...
Status
Completed
Location
Multiple Locations
Start Date
2006-01-01
Trial ID
NCT00291642
The purpose of this study is to evaluate the Plasma Pharmacokinetics and Sa...
Status
Completed
Location
Andover Eye Associates
Start Date
2014-06
Trial ID
NCT02173249
Treatments Being Tested
The purpose of this study is to evaluate the safety and comfort of AC-170 c...
Status
Completed
Location
Andover Eye Associates
Start Date
2011-12
Trial ID
NCT01495338
This is study is evaluating the safety and tolerability of AC-170 Ophthalmi...
Status
Completed
Location
Ora Clinical Site Network
Start Date
2016-04
Trial ID
NCT02756624
Treatments Being Tested
The purpose of this study is to evaluate the safety of AC-170 0.24% used tw...
Status
Completed
Location
Ora, Inc.
Start Date
2014-05
Trial ID
NCT02132169
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of AC-150 compared to...
Status
Completed
Location
Ora, Inc
Start Date
2010-05
Trial ID
NCT01134328
Treatments Being Tested
The purpose of this study is to evaluate the onset and duration of action o...
Status
Completed
Location
Ora, Inc.
Start Date
2012-03
Trial ID
NCT01551056
Treatments Being Tested